Teresa Drudis

1.4k citations
10 papers · 1.1k indexed · 1 hit paper · h-index 8

Teresa Drudis

10 papers receiving 1.1k citations

Hit Papers

The microtubule-affecting drug paclitaxel has antiangioge...19962026200620161996100200300400500

Peers

Teresa Drudis
Comparison fields: 5 of 94
  • Oncology 531
  • Cancer Research 435
  • Molecular Biology 405
  • Surgery 159
  • Pathology and Forensic Medicine 140
Replace Jens Packeisen with:
Jens Packeisen Germany
V. Heilmann Germany
Maria Giulia Cangi Italy
G Bryant United States
E B Bröcker Germany
Bill Angus United Kingdom
Dominic Fong Austria
Luz Hammershaimb United States
G N van Muijen Netherlands
Liotta La United States
Teresa Drudis relative to Jens Packeisen Germany Jens Packeisen's profile →
Citations per field
00.5×1.5×
Jens Packeisen · 1×
Citations per year

Countries citing papers authored by Teresa Drudis

Since Specialization
Citations

This map shows the geographic impact of Teresa Drudis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Drudis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Drudis more than expected).

Fields of papers citing papers by Teresa Drudis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Drudis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Drudis. The network helps show where Teresa Drudis may publish in the future.

Co-authorship network of co-authors of Teresa Drudis

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Drudis. A scholar is included among the top collaborators of Teresa Drudis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Drudis. Teresa Drudis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 98
2 26
3 7
4 23
5
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity.
97
6
The microtubule-affecting drug paclitaxel has antiangiogenic activity.breakdown →
557
7 190
8
The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study.
21
9 94
10 3

About Teresa Drudis

Teresa Drudis is a scholar working on Cancer Research, Oncology and Dermatology, having authored 10 papers that have together received 1.1k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Cancer and Skin Lesions (2 papers). The work is most often cited by research in Cancer Research (435 citations), Oncology (531 citations) and Immunology and Allergy (84 citations). Teresa Drudis has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Raffaella Giavazzi, Patrizia Borsotti, Giulia Taraboletti, Dorina Belotti, G. Viale, Veronica Vergani, Eugenio Scanziani, Angela Garofalo, Peter de Nully Brown and Karen H. van Hoeven. Their work appears in journals such as JNCI Journal of the National Cancer Institute, International Journal of Cancer and The American Journal of Surgical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026